Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hanmi Ventures
South Korea
- Ownership
- Private
- Development stage
- Other
01
Overview
Hanmi Ventures is the corporate venture capital arm established by Hanmi Pharmaceutical Group to invest in early-stage pharmaceutical and biotech opportunities. The firm was launched in 2016 with approximately KRW 10 billion in initial capital and was created to identify promising drug candidates and support biopharma startups as part of Hanmi's open innovation strategy. Available public information indicates that Hanmi Ventures functions primarily as an investment vehicle rather than as a therapeutic product developer with its own disclosed pipeline. It appears closely tied to the broader Hanmi ecosystem and has been associated with healthcare investment activity and strategic scouting in biopharma.
- Industry
- Investors
Beyond the preview
Go deeper on Hanmi Ventures.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hanmi Ventures.